Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine

Neuroscience

Volumn 65, Issue 2, 1995, Pages 385-395

  Cador, M ^a   Bjijou, Y ^a   Stinus, L ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; INTRACEREBRAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SENSITIZATION; VENTRAL TEGMENTUM;

AMPHETAMINE; ANIMAL; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE; MALE; MORPHINE; MOTOR ACTIVITY; NERVE ENDINGS; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; VENTRAL TEGMENTAL AREA;

EID: 0028815346     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(94)00524-9     Document Type: Article

References (45)

1. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment
2. Topography of substantia nigra innervation by D1 receptor-containing striatal neurons
3. Evidence for a selective involvement of dopamine D1 receptors of the VTA in the behavioral sensitization induced by intra-VTA amphetamine injections
4. Enduring enhancement of 5HT1A receptors in the dorsal raphé and transient increase in D1 binding sites in the substantia nigra reticulata in amphetamine sensitized rats
5. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats
6. The long term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro
7. Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats
8. Chronic d-amphetamine in the nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity
9. Amphetamine psychosis I Description of the individual and process
10. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum
11. Morphine induced-activation of A10 dopamine neurons in the rat
12. Environmental and pharmacological sensitization: effects of repeated administration of systemic or intra-nucleus accumbens cocaine
13. 3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum
14. Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release
15. Time-course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya
16. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals
17. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
18. Amphetamine injection into the A10 dopamine region sensitizes rats to peripheral amphetamine, and cocaine
19. The pharmacology and neural circuitry of sensitization to psychostimulants
20. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
21. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioid and GABA: an in vivo microdialysis study
22. Biochemical actions of amphetamine and other stimulants
23. The amphetamine paradox in dopaminergic neurotransmission
24. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat and pituitary: an in situ hybridization-receptor autoradiographic analysis
25. 2 dopamine receptor mRNAs in rat brain
26. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats
27. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine
28. Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity
29. Behavioral sensitization is accompanied by an enhancement in amphetamine stimulated dopamine release from striatal tissue in vitro
30. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis
31. Persistent sensitization of dopamine neurotransmission in ventral striatum with (+)-amphetamine: a microdialysis study in freely moving rats
32. Acute exacerbation of paranoid psychotic state after long term abstinence in patient with previous metamphetamine psychosis
33. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat
34. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment
35. Microinjections of SCH-23390 into ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine
36. Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic metamphetamine administration
37. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat
38. Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist DAGO administered repeatedly to the ventral tegmental area but not to the nucleus accumbens
39. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects
40. Dopaminergic neurons in the rat ventral tegmental area. II. Evidence for autoregulation
41. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic d-amphetamine treatment
42. Enduring enhancement in amphetamine-stimulated striatal dopamine release in vitro produced by prior exposure to amphetamine or stress in vivo